Antares Pharma (NASDAQ:ATRS) stated gains of 386,281 shares or 4.5% in the short interest. The short interest registered from 8,589,052 on May 31,2016 to 8,975,333 on June 15,2016. In terms of floated shares, the shorted positions stood at 6.6%. The stock has been averaging 711,621 shares daily in trading and would need 13 days to cover the shorts. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
Antares Pharma (NASDAQ:ATRS): The stock opened at $0.97 on Friday but the bulls could not build on the opening and the stock topped out at $0.99 for the day. The stock traded down to $0.92 during the day, due to lack of any buying support eventually closed down at $0.95 with a loss of -5.62% for the day. The stock had closed at $1.01 on the previous day. The total traded volume was 15,396,816 shares.
The company shares have dropped -54.98% from its 1 Year high price. On Jul 15, 2015, the shares registered one year high at $2.35 and the one year low was seen on Mar 18, 2016. The 50-Day Moving Average price is $0.97 and the 200 Day Moving Average price is recorded at $1.00.
Antares Pharma (NASDAQ:ATRS) has tumbled 5.62% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 3.81% in the last four weeks. The stocks have underperformed the S&P 500 by 4.06% during the past week but Antares Pharma (NASDAQ:ATRS) it has outperformed the index in 4 weeks by 6.95%.
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical Company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures for itself and with partners, pressure-assisted injectors, with and without needles, which allow patients to self-inject drugs. It has developed variations of the needle-free injector by adding a small shielded needle to a pre-filled, single-use disposable injector, called the Vibex pressure assisted auto injection system. This system is an alternative to the needle-free system for use with injectable drugs in unit dose containers and is suitable for branded and generic injectables. It has also developed a disposable multi-dose pen injector for use with standard cartridges.